Return to Today's science sparks archives

2019-01-02

Fig. 1 Lymphoma cells with BCL2/PMAIP1 coamplification are highly sensitive to BCL-2 inhibitor.

Fig. 1 Lymphoma cells with BCL2/PMAIP1 coamplification are highly sensitive to BCL-2 inhibitor.
  • Liu Y, Mondello P, Erazo T, Tannan NB, Asgari Z, de Stanchina E, Nanjangud G, Seshan VE, Wang S, Wendel HG, Younes A

  • Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):12034-12039.
Open Access button

2019-01-03

Fig. 1 a) Dicentric chromosomes are formed by the fusion of dysfunctional telomeres during telomere crisis.

Fig. 1 a) Dicentric chromosomes are formed by the fusion of dysfunctional telomeres during telomere crisis.
  • von Morgen P, Maciejowski J

  • Genome Med. 2018 Nov 27;10(1):89.
Open Access button

2019-01-04

Fig. 2 (A) Working group consensus on preferred end points by biologic subtype and line of therapy. (B) Hypothetical scenarios for expected postprogression survival (PPS) and choice of preferred end point.

Fig. 2 (A) Working group consensus on preferred end points by biologic subtype and line of therapy. (B) Hypothetical scenarios for expected postprogression survival (PPS) and choice of preferred end point.
  • Seidman AD, Bordeleau L, Fehrenbacher L, Barlow WE, Perlmutter J, Rubinstein L, Wedam SB, Hershman DL, Hayes JF, Butler LP, Smith ML, Regan MM, Beaver JA, Amiri-Kordestani L, Rastogi P, Zujewski JA, Korde LA

  • J Clin Oncol. 2018 Sep 13:JCO1800242.

2019-01-07

Fig. 2 FAT1 loss and clinical resistance.

Fig. 2 FAT1 loss and clinical resistance.
  • Li Z, Razavi P, Li Q, Toy W, Liu B, Ping C, Hsieh W, Sanchez-Vega F, Brown DN, Da Cruz Paula AF, Morris L, Selenica P, Eichenberger E, Shen R, Schultz N, Rosen N, Scaltriti M, Brogi E, Baselga J, Reis-Filho JS, Chandarlapaty S

  • Cancer Cell. 2018 Dec 10;34(6):893-905.e8.

2019-01-08

Fig. 1 Tyrosine kinase inhibitors and antibodies or antibody–drug conjugates in clinical use or under clinical investigation to target EGFR, HER2, and HER3 in EGFR-mutant lung cancers.

Fig. 1 Tyrosine kinase inhibitors and antibodies or antibody–drug conjugates in clinical use or under clinical investigation to target EGFR, HER2, and HER3 in EGFR-mutant lung cancers.
  • Fan PD, Yu HA

  • Clin Cancer Res. 2018 Nov 15;24(22):5499-5501.

2019-01-09

Fig. 1 Reliability of somatic SNVs and INDELs detected by WES and high-depth amplicon sequencing validation of variants.

Fig. 1 Reliability of somatic SNVs and INDELs detected by WES and high-depth amplicon sequencing validation of variants.
  • Shi W, Ng CKY, Lim RS, Jiang T, Kumar S, Li X, Wali VB, Piscuoglio S, Gerstein MB, Chagpar AB, Weigelt B, Pusztai L, Reis-Filho JS, Hatzis C

  • Cell Rep. 2018 Nov 6;25(6):1446-1457.
Open Access button

2019-01-10

Fig. 1 Chimeric Antigen Receptor (CAR) design across generations.

Fig. 1 Chimeric Antigen Receptor (CAR) design across generations.
  • Boyiadzis MM, Dhodapkar MV, Brentjens RJ, Kochenderfer JN, Neelapu SS, Maus MV, Porter DL, Maloney DG, Grupp SA, Mackall CL, June CH, Bishop MR

  • J Immunother Cancer. 2018 Dec 4;6(1):137.
Open Access button

2019-01-11

Fig. 1 Coronal image from a whole body CT demonstrating a color-coded map of voxels with mean HU values within the range −29 and +150 (colored green on this image).

Fig. 1 Coronal image from a whole body CT demonstrating a color-coded map of voxels with mean HU values within the range −29 and +150 (colored green on this image).
  • Halpenny DF, Goncalves M, Schwitzer E, Golia Pernicka J, Jackson J, Gandelman S, Moskowitz CS, Postow M, Mourtzakis M, Caan B, Jones LW, Plodkowski AJ

  • Br J Radiol. 2018 Dec;91(1092):20180451.

2019-01-14

Fig. 3 Schistosome eggs involving the bladder wall.

Fig. 3 Schistosome eggs involving the bladder wall.
  • Park S, Reuter VE, Hansel DE

  • Histopathology. 2019 Jan;74(1):97-111.

2019-01-15

Fig. 1  Colonoscopy quality reporting by method. ADR indicates adenoma detection rate; NLP, natural language processing.

Fig. 1 Colonoscopy quality reporting by method. ADR indicates adenoma detection rate; NLP, natural language processing.
  • Lee JK, Jensen CD, Levin TR, Zauber AG, Doubeni CA, Zhao WK, Corley DA

  • J Clin Gastroenterol. 2019 Jan;53(1):e25-e30.